Evidence map›Paper›PMID 39905957›Full record

ArticleInorganic chemistry2025

Dual-Action NO Delivery from One Mixed Metal Metal-Organic Framework.

Russell M Main, Aaron B Naden, Morven J Duncan, Russell E Morris, Romy Ettlinger

Abstract read
In one paragraph

Article in Inorganic chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Therapeutic Gases in Biomedicine: Updates on Nitric Oxide and Beyond.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Russell M MainEaStCHEM School of Chemistry, University of St Andrews, Purdie Building, North Haugh, St Andrews KY16 9ST, U.K.ORCID 0000-0003-2212-7013
Aaron B NadenEaStCHEM School of Chemistry, University of St Andrews, Purdie Building, North Haugh, St Andrews KY16 9ST, U.K.
Morven J DuncanEaStCHEM School of Chemistry, University of St Andrews, Purdie Building, North Haugh, St Andrews KY16 9ST, U.K.ORCID 0000-0001-9485-2543
Russell E MorrisEaStCHEM School of Chemistry, University of St Andrews, Purdie Building, North Haugh, St Andrews KY16 9ST, U.K.ORCID 0000-0001-7809-0315
Romy EttlingerEaStCHEM School of Chemistry, University of St Andrews, Purdie Building, North Haugh, St Andrews KY16 9ST, U.K.ORCID 0000-0001-7063-9908

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Owing to their varied and controllable reticular chemistry, metal-organic frameworks (MOFs) represent excellent, structurally precise material platforms for creating multifunctional devices. This flexibility allows the design of MOFs to feature two different delivery mechanisms for the medicinal gas nitric oxide (NO) within one structure: a rapid, kinetic release of preadsorbed NO and subsequent continuous, catalytic generation of NO on exposure to a suitable substrate. In our approach, this was realized by preparing mixed metal MOF-74 analogues (also known as CPO-27) combining two metals, namely, nickel and copper. The introduction of 10 atom % nickel into Cu-MOF-74 provides a material platform with a number of excellent properties: (i) a high capacity of NO can be released with a moisture-triggered mechanism; (ii) the available copper sites allow the (potentially indefinite) catalytic generation of NO in the presence of S-nitrosoglutathione (GSNO), a store of NO in the human body; and (iii) it features prolonged material stability on exposure to phosphates. This material therefore shows great promise as part of the next generation of multifunctional MOF-based medicinal devices.

Identifiers

PMID39905957
PMCPMC11898063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.